Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: brca1 Mutation Carrier|brca2 Mutation Carrier|Breast Cancer|Ovarian Cancer
Interventions: DRUG: rucaparib (CO-338; formally AG-014699 or PF-01367338)|GENETIC: protein expression analysis|GENETIC: western blotting|OTHER: immunohistochemistry staining method|OTHER: liquid chromatography|OTHER: mass spectrometry|OTHER: pharmacological study
Sponsor: Cancer Research UK